Adage Capital Partners’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
Adage Capital Partners's IONS Position: Q3 2026 in Review
Adage Capital Partners sold out of Ionis Pharmaceuticals (IONS) in Q3 2026, closing a stake of 150,000 shares — an estimated $11.9M sold.
Adage Capital Partners first reported a position in IONS in Q3 2023 and held it in 12 quarters. The position peaked at $150M in Q2 2025. 465 funds tracked by Wall St. Rank hold IONS as of Q3 2026.
- Adage Capital Partners reported no remaining Ionis Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Adage Capital Partners sold 150,000 Ionis Pharmaceuticals shares in Q3 2026, an estimated $11.9M.
- Adage Capital Partners first reported a position in Ionis Pharmaceuticals in Q3 2023 and held it in 12 quarters.
- Adage Capital Partners's Ionis Pharmaceuticals position peaked at $150M in Q2 2025.
- 465 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.
Based on Adage Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.